AUPQ026799A0 - Method of increasing protein stability by removing immunoglobulin aggregates - Google Patents
Method of increasing protein stability by removing immunoglobulin aggregatesInfo
- Publication number
- AUPQ026799A0 AUPQ026799A0 AUPQ0267A AUPQ026799A AUPQ026799A0 AU PQ026799 A0 AUPQ026799 A0 AU PQ026799A0 AU PQ0267 A AUPQ0267 A AU PQ0267A AU PQ026799 A AUPQ026799 A AU PQ026799A AU PQ026799 A0 AUPQ026799 A0 AU PQ026799A0
- Authority
- AU
- Australia
- Prior art keywords
- protein stability
- increasing protein
- immunoglobulin aggregates
- removing immunoglobulin
- aggregates
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39591—Stabilisation, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPQ0267A AUPQ026799A0 (en) | 1999-05-10 | 1999-05-10 | Method of increasing protein stability by removing immunoglobulin aggregates |
AU43855/00A AU4385500A (en) | 1999-05-10 | 2000-05-10 | High concentration immunoglobulin preparation and method for its production |
PCT/AU2000/000433 WO2000067789A1 (en) | 1999-05-10 | 2000-05-10 | High concentration immunoglobulin preparation and method for its production |
EP00924972A EP1176979A4 (en) | 1999-05-10 | 2000-05-10 | High concentration immunoglobulin preparation and method for its production |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPQ0267A AUPQ026799A0 (en) | 1999-05-10 | 1999-05-10 | Method of increasing protein stability by removing immunoglobulin aggregates |
Publications (1)
Publication Number | Publication Date |
---|---|
AUPQ026799A0 true AUPQ026799A0 (en) | 1999-06-03 |
Family
ID=3814474
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AUPQ0267A Abandoned AUPQ026799A0 (en) | 1999-05-10 | 1999-05-10 | Method of increasing protein stability by removing immunoglobulin aggregates |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1176979A4 (en) |
AU (1) | AUPQ026799A0 (en) |
WO (1) | WO2000067789A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040033228A1 (en) | 2002-08-16 | 2004-02-19 | Hans-Juergen Krause | Formulation of human antibodies for treating TNF-alpha associated disorders |
JP4586027B2 (en) | 2004-01-30 | 2010-11-24 | シャイア ファーマシューティカルズ アイルランド リミテッド | Production and purification of recombinant arylsulfatase A |
WO2007112757A2 (en) * | 2006-04-04 | 2007-10-11 | Zymenex A/S | A process for concentration of a polypeptide |
EP2142565A4 (en) | 2007-03-29 | 2010-03-31 | Abbott Lab | Crystalline anti-human il-12 antibodies |
US8883146B2 (en) | 2007-11-30 | 2014-11-11 | Abbvie Inc. | Protein formulations and methods of making same |
US20110166332A1 (en) * | 2008-09-12 | 2011-07-07 | Ge Healthcare Bio-Sciences Ab | Enhanced antibody aggregate removal with capto adhere in the presence of protein-excluded zwitterions |
KR101464032B1 (en) * | 2009-05-27 | 2014-11-27 | 백스터 인터내셔널 인코포레이티드 | A method to produce a highly concentrated immunoglobulin preparation for subcutaneous use |
EP2729566B1 (en) | 2011-07-08 | 2017-03-15 | Shire Human Genetic Therapies, Inc. | Methods for purification of arylsulfatase a |
SG10201705668XA (en) | 2012-09-07 | 2017-08-30 | Coherus Biosciences Inc | Stable aqueous formulations of adalimumab |
AU2014205441B2 (en) | 2013-01-09 | 2019-12-12 | Takeda Pharmaceutical Company Limited | Methods for purification of arylsulfatase A |
US11229702B1 (en) | 2015-10-28 | 2022-01-25 | Coherus Biosciences, Inc. | High concentration formulations of adalimumab |
US11071782B2 (en) | 2016-04-20 | 2021-07-27 | Coherus Biosciences, Inc. | Method of filling a container with no headspace |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3310150A1 (en) * | 1983-03-21 | 1984-09-27 | Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München | METHOD FOR PRODUCING A IGG IMMUNOGLOBULIN SOLUTION WITHOUT SIDE EFFECTS FOR THE INTRAVENOUS APPLICATION |
US4597966A (en) * | 1985-01-09 | 1986-07-01 | Ortho Diagnostic Systems, Inc. | Histidine stabilized immunoglobulin and method of preparation |
CA1310267C (en) * | 1986-07-09 | 1992-11-17 | Yutaka Hirao | Process for heat treating chemically unmodified _-globulin |
DE3641115A1 (en) * | 1986-12-02 | 1988-06-16 | Lentia Gmbh | METHOD FOR PRODUCING AN INTRAVENOUS APPLICABLE AND STABLE IN LIQUID FORM IMMUNOGLOBULINS |
US5656730A (en) * | 1995-04-07 | 1997-08-12 | Enzon, Inc. | Stabilized monomeric protein compositions |
AU3429797A (en) * | 1996-07-18 | 1998-02-10 | Csl Limited | Pasteurization of immunoglobulin solutions |
GB9705810D0 (en) * | 1997-03-20 | 1997-05-07 | Common Services Agency | Intravenous immune globulin |
BR9911131A (en) * | 1998-06-09 | 2001-03-06 | Statens Seruminstitut | Process for producing immunoglobulins for intravenous administration and other immunoglobulin products |
-
1999
- 1999-05-10 AU AUPQ0267A patent/AUPQ026799A0/en not_active Abandoned
-
2000
- 2000-05-10 WO PCT/AU2000/000433 patent/WO2000067789A1/en not_active Application Discontinuation
- 2000-05-10 EP EP00924972A patent/EP1176979A4/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1176979A1 (en) | 2002-02-06 |
WO2000067789A1 (en) | 2000-11-16 |
EP1176979A4 (en) | 2005-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001294175A1 (en) | Method of purifying antibody | |
AU2001240115A1 (en) | Method for the preparation of tetrahydrobenzothiepines | |
AU5005700A (en) | Method for the manufacture of toothpaste | |
AU2002353458A1 (en) | Method for the preparation of aggregates | |
AUPQ026799A0 (en) | Method of increasing protein stability by removing immunoglobulin aggregates | |
AU2002353310A1 (en) | Method for the preparation of nucleic acids | |
AU1683200A (en) | Method for improving gelling properties of protein | |
AU4552200A (en) | Method of treating psychotic disorders | |
AU2354800A (en) | Method of protein removal | |
AU2001294258A1 (en) | Method of purifying plavastatin | |
AU2001231086A1 (en) | Method of affinity purifying proteins using modified bis-arsenical fluorescein | |
AU2376001A (en) | Method for the manufacture of olefins | |
AU2169201A (en) | Method for the isolation of hydrophobic proteins | |
AUPP385598A0 (en) | Purification of antibodies | |
AU2001287695A1 (en) | Method for purifying recombinant proteins expressed as insoluble aggregates | |
AU4441200A (en) | Method for transforming chords | |
AU2001260220A1 (en) | Method for modification of proteins by transglutaminase | |
AU1683100A (en) | Method for improving solubility of protein | |
AU5977599A (en) | Method for the rectificative separation of chlorosilanes | |
AU6300500A (en) | Method for identifying interacting proteins | |
AU2001253092A1 (en) | Method for detection of truncated proteins | |
AU1478201A (en) | Improved method of immunization | |
AU4575800A (en) | Purification method by affinity | |
AU1784701A (en) | Method of treating neuroblastoma | |
AU4914600A (en) | Method for treating tnf-receptor type-2-induced diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAA1 | Application designating australia and claiming priority from australian document |
Ref document number: 4385500 Country of ref document: AU |